Skip to content

HVII HVII Sale of stock, price per share (in dollars per share)

Sale of stock, price per share (in dollars per share) at other companies

Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$0.01
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$60.00
electroCore, Inc. logo
electroCore, Inc.ECOR
$6.62
SKYX Platforms Corp. logo
SKYX Platforms Corp.SKYX
$1.20
CBAK Energy Technology, Inc. logo
CBAK Energy Technology, Inc.CBAT
$5.18
New America Acquisition I
 logo
New America Acquisition I NWAX
$10.00

Other financials

Income statement

See full
Operating income-$1.1M-124%
Net income$575.6K-43.5%
EPS (diluted)$0.02-60.0%

Balance sheet

See full
Cash & equivalents$323.2K-84.2%
Total equity-$10.1M-11.4%
Total assets$199.3M+2.9%

Cash flow

See full
Operating cash flow-$644.7K-32.0%

Valuation

See full
Market cap$271.94M+3.0%
P/E82.7×-23.8×

Returns & leverage

See full
Return on equity-39.5%
Current ratio6.8×-8.4×

Where this comes from

Reported directly by HVII in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockPricePerShare.

The official record: HVII’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about HVII's sale of stock, price per share (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is HVII's sale of stock, price per share (in dollars per share)?
HVII (HVII) reported sale of stock, price per share (in dollars per share) of $10.00 in Q1 2025.
What does sale of stock, price per share (in dollars per share) mean?
This metric reflects the specific price at which equity securities were sold during a capital raising event or private placement. It provides insight into the valuation assigned to the company's shares by investors at a particular point in time.